Male Breast Cancer Completed Phase 2 Trials for Filgrastim (DB00099)

Also known as: Breast Cancer, Male / Breast Cancer - Male / Breast cancer male / Cancer of male breast / Malignant neoplasm of male breast (disorder) / Carcinoma of male breast (disorder) / Breast cancer male NOS

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00119262
Bevacizumab and Combination Chemotherapy in Patients With Lymph Node Positive Breast CancerTreatment
NCT00513695
Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast CancerTreatment